Loading...
XJPX
2107
Market cap0kUSD
May 30, Last price  
2,073.00JPY
Name

Toyo Sugar Refining Co Ltd

Chart & Performance

D1W1MN
P/E
0.00
P/S
0.00
EPS
216,142,857.14
Div Yield, %
2.89%
Shrs. gr., 5y
—
Rev. gr., 5y
4.94%
Revenues
17.41b
+15.04%
14,250,000,00014,193,000,00014,447,000,00015,027,000,00015,555,000,00014,691,000,00014,478,000,00014,419,000,00014,469,000,00014,370,000,00013,924,000,00013,677,000,00013,515,000,00012,908,000,00013,403,000,00015,131,000,00017,407,000,000
Net income
1.51b
+229.63%
629,000,000489,000,000738,000,000798,000,000714,000,000657,000,000517,000,000-781,000,000528,000,000596,000,000700,000,000727,000,000758,000,000295,000,000514,000,000459,000,0001,513,000,000
CFO
1.48b
+996.30%
1,218,000,00042,000,0001,003,000,0001,133,000,000778,000,000680,000,000727,000,000518,000,000854,000,000394,000,000439,000,0001,479,000,000685,000,000631,000,000658,000,000135,000,0001,480,000,000
Dividend
Mar 28, 20250 JPY/sh
Earnings
Aug 05, 2025

Profile

Toyo Sugar Refining Co., Ltd. engages in the refining and sale of sugar in Japan. The company provides granulated, white and brown soft, crystal, and liquid sugar products. It also manufactures and sells alpha glucosyl stevioside, rutin, hesperidin, and soy isoflavone used in food, beverage, supplement, skin care, and pharmaceutical applications; C-mo 2G, a glyceryl glucoside used in various skin care and hair care products; Baobab Sariche, an adansonia digitata seed oil used in skin care and hair care products; and Citron Polyphenol, a water soluble polyphenol extracted from citrus maxim used in personal care products. In addition, the company offers Oligonol, a polyphenol used in food, nutraceutical, and cosmetics applications; and Perilla Leaf Extract used in traditional Chinese medicines for anti-febrile, pain relieving, and coughs suppressing effects. Toyo Sugar Refining Co., Ltd. was founded in 1949 and is headquartered in Tokyo, Japan.
URL
https://www.toyosugar.co.jp/
IPO date
Mar 25, 1953
Employees
72
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
17,407,000
15.04%
15,131,000
12.89%
Cost of revenue
16,388,000
14,845,000
Unusual Expense (Income)
NOPBT
1,019,000
286,000
NOPBT Margin
5.85%
1.89%
Operating Taxes
455,000
76,000
Tax Rate
44.65%
26.57%
NOPAT
564,000
210,000
Net income
1,513,000
229.63%
459,000
-10.70%
Dividends
(502,000)
(190,000)
Dividend yield
3.67%
3.84%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
5,000
5,000
Long-term debt
45,000
57,000
Deferred revenue
Other long-term liabilities
386,000
400,000
Net debt
(7,615,000)
(4,889,000)
Cash flow
Cash from operating activities
1,480,000
135,000
CAPEX
(71,000)
(40,000)
Cash from investing activities
(125,000)
(11,000)
Cash from financing activities
(507,000)
(195,000)
FCF
(729,000)
(81,000)
Balance
Cash
4,604,000
3,756,000
Long term investments
3,061,000
1,195,000
Excess cash
6,794,650
4,194,450
Stockholders' equity
11,153,000
10,004,000
Invested Capital
4,767,350
6,204,550
ROIC
10.28%
3.53%
ROCE
8.81%
2.75%
EV
Common stock shares outstanding
5,453
5,453
Price
2,510.00
176.43%
908.00
-11.15%
Market cap
13,686,187
176.43%
4,951,040
-11.15%
EV
6,071,187
62,040
EBITDA
1,093,000
352,000
EV/EBITDA
5.55
0.18
Interest
Interest/NOPBT